'Treatment duration for Escherichia coli bloodstream infection and outcomes' - Author's reply

被引：1

作者：

Giannella, M. ^{[1
]}

Pascale, R. ^{[1
]}

Viale, P. ^{[1
]}

机构：

[1] Univ Bologna, Policlin St Orsola Malpighi, Dept Med & Surg Sci, Infect Dis Unit, Bologna, Italy

来源：

CLINICAL MICROBIOLOGY AND INFECTION | 2019年 / 25卷 / 05期

关键词：

ANTIMICROBIAL THERAPY;

D O I：

10.1016/j.cmi.2018.12.004

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：641 / 642

页数：2

共 4 条

[1] Treatment duration for Escherichia coli bloodstream infection and outcomes: retrospective single-centre study [J].

Giannella, M. ;

Pascale, R. ;

Toschi, A. ;

Ferraro, G. ;

Graziano, E. ;

Furii, F. ;

Bartoletti, M. ;

Tedeschi, S. ;

Ambretti, S. ;

Lewis, R. E. ;

Viale, P. .

CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (10) :1077-1083

[2] Re: 'Treatment duration for Escherichia coli bloodstream infection and outcomes' by Giannella et al. [J].

Karakonstantis, S. .

CLINICAL MICROBIOLOGY AND INFECTION, 2019, 25 (05) :640-640

[3] Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections [J].

Nelson, Avery N. ;

Justo, Julie Ann ;

Bookstaver, P. Brandon ;

Kohn, Joseph ;

Albrecht, Helmut ;

Al-Hasan, Majdi N. .

INFECTION, 2017, 45 (05) :613-620

[4] The antimicrobial therapy puzzle: Could pharmacokinetic-pharmacodynamic relationships be helpful in addressing the issue of appropriate pneumonia treatment in critically ill patients? [J].

Pea, Federico ;

Viale, Pierluigi .

CLINICAL INFECTIOUS DISEASES, 2006, 42 (12) :1764-1771

← 1 →